217 results
Page 6 of 11
8-K
EX-99.1
qy9l832udu tnkq
23 Sep 22
Regulation FD Disclosure
8:00am
8-K
5inyc8wutktimd
23 Sep 22
Regulation FD Disclosure
8:00am
425
uu5tg woapaog
14 Sep 22
Business combination disclosure
4:04pm
8-K
uedt1u8m
14 Sep 22
Kineta CSO Thierry Guillaudeux Invited to Participate at the 2nd Annual VISTA Virtual Symposium
4:01pm
425
ecaln9b0wazyy1lzp
12 Sep 22
Business combination disclosure
4:01pm
8-K
il0tn37zo57
12 Sep 22
Kineta Announces Participation in the H.C. Wainwright 24th Annual Global Healthcare Conference
4:00pm
425
cwqkjjys6kj
29 Aug 22
Business combination disclosure
4:03pm
8-K
hir4h4x7wt
29 Aug 22
Yumanity Therapeutics Announces Filing of Registration Statement on Form S-4 In Connection With Proposed Asset Sale to Janssen and Merger with Kineta
4:01pm
8-K
EX-99.1
ku1sx
29 Aug 22
Yumanity Therapeutics Announces Filing of Registration Statement on Form S-4 In Connection With Proposed Asset Sale to Janssen and Merger with Kineta
4:01pm
8-K
jvong6mi5 whwes
4 Aug 22
Yumanity Therapeutics Reports Second Quarter 2022 Financial Results and Recent Corporate Developments
4:51pm
8-K
EX-99.1
as1 5nqw9k
4 Aug 22
Yumanity Therapeutics Reports Second Quarter 2022 Financial Results and Recent Corporate Developments
4:51pm
425
0wt4r ng11s
20 Jul 22
Business combination disclosure
6:09am
8-K
EX-99.1
ahdem4
20 Jul 22
Regulation FD Disclosure
6:07am
8-K
rkygi4y9y3b5n f8k12k
20 Jul 22
Regulation FD Disclosure
6:07am
425
ij3s z65q7npbhkiy
28 Jun 22
Business combination disclosure
4:03pm
8-K
i3wgq3gfjazf edh15us
28 Jun 22
Kineta Announces Appointment of Thierry Guillaudeux, PhD to Chief Scientific Officer
4:02pm
425
5ew4kf1tui 935h
17 Jun 22
Business combination disclosure
4:03pm
8-K
3a8dg2
17 Jun 22
Kineta Presents New Preclinical Data and Phase 1/2 Clinical Trial Design of KVA12.1 at the Tumor Myeloid-Directed Therapies Summit
4:02pm